Stock Earnings
VNRX Stock Sees Surge of Approximately 8.69% in Last Five Days
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
VolitionRX Ltd’s filing revealed that its Chief Scientific Officer Micallef Jacob Vincent acquired Company’s shares for reported $21500.0 on May
After signing a global supply agreement, VolitionRx Limited (NYSE: VNRX) increased 19.31% to $1.73 in the current market on Thursday.